Developer docs
API playgroundTry for free, no card

Search company profiles

Carterra- LSA platform

Full company profile

uuid0025ls7

Namestring
Carterra- LSA platform
Legal namestring
Carterra, Inc.
Company typeenum
Private
Founded yearint
2005
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSalt Lake City, United States
HQ citystring
Salt Lake City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
surface plasmon resonance, antibody screening platforms, kinetics characterization, epitope binning systems, biopharmaceutical instrumentation
Industry3 codes
PRIMARYHLAAAIAA
High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Biopharmaceutical Analytical Instruments
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1SPR Instrumentation Sales
TypeHardware Sales
Description

Sale of high-throughput SPR instruments including LSA, LSAXT, Ultra, and Carterra Vega platforms. Instruments are capital equipment requiring significant investment, sold through enterprise field sales.

carterra-bio.com
2Sensor Chips and Consumables
TypeHardware Sales
Description

Recurring revenue from proprietary sensor chips (HC, CMD, NiNTA, Streptavidin, Protein A/G series) and consumables required for SPR operations. Online store available for chip purchases.

carterra-bio.com
3Software Licenses and Updates
TypeSubscription Recurring
Description

Kinetics and Epitope Data Analysis Software with regular version updates. Software updates released periodically (e.g., V.2.0.0.5078 in October 2025) with new features and capabilities.

carterra-bio.com
4Service and Support
TypeProfessional Services
Description

Technical support, application training programs, and service contracts for installed customer base. Dedicated support team with phone and email contact options.

carterra-bio.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Carterra LSA
Description

High-throughput SPR platform for detailed antibody kinetic and epitope binning characterization, supporting up to 384x384 interactions.

carterra-bio.com
+5 more records
Core offering1 text field

Carterra designs, manufactures, and sells high-throughput Surface Plasmon Resonance (HT-SPR) instrumentation and associated consumables and software for antibody screening, kinetic characterization, and epitope binning. The LSA, LSAXT, Ultra, and Vega instruments measure binding interactions for therapeutic discovery at biopharmaceutical companies, biotechs, and academic and government research organizations, complemented by proprietary sensor chips, Navigator control software, and Kinetics and Epitope Data Analysis Software.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 90 days from antibody screening initiation to human treatment (Eli Lilly COVID-19 antibody program)
+3 more records
Product overview1 text field

Carterra offers a portfolio of four HT-SPR (High-Throughput Surface Plasmon Resonance) platforms sharing common technology and software. The Carterra LSA serves as the core antibody characterization platform for detailed kinetics and epitope binning. The LSAXT extends capabilities with enhanced sensitivity for PROTACs, kinases, and cytokines. The Ultra platform targets small molecule and fragment screening with maximum sensitivity. The Vega represents the latest addition as a 48-channel parallel SPR platform for massively increased throughput. All instruments share common Navigator software for experiment control, Kinetics Data Analysis Software for kinetic screening, and Epitope Data Analysis Software for binning analysis. The platforms are complemented by a range of sensor chip consumables and integrated AI/ML tools for data-driven drug discovery.

Product and service9 records
1Carterra LSA
CategoryHT-SPR Instrument
Description

High-throughput SPR instrument for detailed antibody kinetic analysis and epitope binning, enabling screening of up to 1,152 monoclonal antibodies in a single unattended run for pharmaceutical and biotech discovery teams.

2Carterra LSAXT
CategoryHT-SPR Instrument
Description

Enhanced sensitivity SPR instrument for PROTAC, kinase, cytokine, DEL, and protein-protein inhibitor screening and characterization, designed for biotherapeutic discovery teams.

3Carterra Ultra
CategoryHT-SPR Instrument
Description

High-sensitivity HT-SPR instrument for small molecule and fragment screening with 96-channel printhead, advanced microfluidics, and capacity for up to 768 fragments or 1,152 mAbs per run.

4Carterra Vega
CategoryHT-SPR Instrument
Description

48-channel parallel HT-SPR platform delivering 12x the throughput of leading 8-channel SPR systems, screening over 20,000 analytes per day for high-volume biotherapeutic and small molecule discovery programs.

5Sensor Chips
CategoryConsumables
Description

Proprietary biosensor chips including HC, CMD, NiNTA, Streptavidin, Protein A, and Protein A/G surface chemistries used as consumables for Carterra HT-SPR instruments.

6Kinetics Data Analysis Software
CategoryAnalysis Software
Description

High-throughput kinetics analysis software for screening and ranking up to 1,152 monoclonal antibodies with rapid data fitting, visualization, quality validation, and interactive on-rate, off-rate, affinity, and iso-affinity plots.

7Epitope Data Analysis Software
CategoryAnalysis Software
Description

Epitope binning and mapping analysis software for processing massive 384x384 HT-SPR datasets with heat maps, dendrograms, network plots, and stacked plots for visualization.

8Navigator Software
CategoryControl Software
Description

Experiment setup and run control software with assay wizards enabling complex assay setup in under 5 minutes, fully automated experiments, real-time binding data collection, and up to 7 days of unattended operation.

9AI, ML and Synthetic Biology Tools
CategoryApplication Tools
Description

Integrated AI/ML workflows and synthetic biology tools leveraging Carterra HT-SPR binding data to support machine learning and generative AI applications in antibody design and drug discovery.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Revvity Signals
Strategic tierCoreTypeTechnology or Integration
Description

Integration partnership with Revvity's Signals VitroVivo (formerly Signals Screening) software v2.7+ for data management. Enables single repository for organizing HT-SPR experimental data, comparison with orthogonal methods, and integration with TIBCO Spotfire analytics. Supports AI/ML workflows with curated data.

carterra-bio.com
Strategic tierCoreTypeTechnology or Integration
Description

Generate Biomedicines uses Carterra LSA as integral part of their machine learning-driven protein design platform. Quote from Brett Blakeley, Senior Scientist: 'The Carterra LSA is the only instrument that can deliver high-resolution binding data at this level of throughput.' Demonstrates platform utility for AI/ML applications.

Strategic tierCoreTypeTechnology or Integration
Description

Absci uses Carterra LSA platform for AI in medical research, leveraging HT-SPR data for machine learning applications in drug discovery.

4Carna Biosciences
Strategic tierStrategicTypeTechnology or Integration
Description

Collaboration with Carna Biosciences to develop kinase drug discovery solutions. Carterra uses Carna Biosciences kinases for demonstrating kinome profiling capabilities on their platforms.

carterra-bio.com
Strategic tierStrategicTypeTechnology or Integration
Description

GSK collaboration for DNA-encoded library screening and hit validation using HT-SPR technology. Carterra presented at GSK on high-throughput SPR applications in DEL screening.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Thermo Fisher is a broad incumbent in life-science analytical instruments, offering a portfolio that includes biophysical characterization tools (e.g., MicroCal PEAQ-ITC, GCI systems) and adjacent label-free technologies. While not a direct SPR competitor, Thermo Fisher competes broadly for the same pharma instrument budgets.

TypeBroad incumbent
Description

Bruker operates a broader life-science instrumentation portfolio and has participated in SPR-related technologies through acquisitions. While not a single-product SPR competitor, Bruker is a broad incumbent in life-science analytical instruments that occasionally overlaps with Carterra's customer workflows.

TypeOthers
Description

Revvity provides data management and analytics software (Signals VitroVivo/Screening) that integrates with Carterra LSA instruments for pharma screening workflows. It is an enabling technology partner and adjacent ecosystem participant rather than a direct SPR competitor.

TypeDirect peer
Description

Reichert (part of Ametek) manufactures SPR-based instruments (e.g., SR7500DC) for label-free interaction analysis in research and pharma settings. Reichert is a long-standing SPR competitor with a smaller installed base than Biacore but overlapping customer workflows in protein characterization.

TypeEmerging player
Description

Nicoya offers OpenSPR, a benchtop localized surface plasmon resonance (LSPR) instrument targeted at academic and smaller biotech researchers. It is an emerging player competing in entry-level SPR workflows and represents a differentiated price-point alternative to Carterra's high-throughput platforms.

TypeDirect peer
Description

Sartorius markets the Octet platform based on bio-layer interferometry (BLI), the principal orthogonal label-free binding kinetics technology competing with SPR in antibody characterization and screening workflows at biopharma customers. Octet targets many of the same use cases (kinetics, epitope binning, quantitation) as Carterra's HT-SPR.

TypeEmerging player
Description

Attana develops label-free biosensor instruments based on QCM (quartz crystal microbalance) technology for real-time interaction analysis. As a smaller, niche player in label-free kinetics, Attana competes with Carterra in select academic and biotech segments for binding characterization applications.

TypeBroad incumbent
Description

Agilent provides a broad portfolio of analytical and life-science instruments, including biophysical characterization and screening tools that serve overlapping biopharma customers. While not a focused SPR competitor, Agilent competes at the portfolio level for instrument wallet share at major pharma accounts.

TypeDirect peer
Description

Cytiva (formerly GE Healthcare Life Sciences) manufactures the Biacore line of SPR instruments, the entrenched incumbent in label-free binding kinetics for biopharma R&D. Biacore is the closest direct competitor to Carterra across the same customer base, with decades of installed instruments at virtually every major pharma company.

TypeEmerging player
Description

NanoTemper's Monolith platform uses microscale thermophoresis (MST) for label-free binding affinity analysis, competing with SPR and BLI in protein-small molecule and protein-protein interaction characterization. It is an emerging player in adjacent label-free biophysics serving overlapping pharma/biotech customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers18 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Carterra- LSA platform

Biopharmaceutical Analytical Instrumentscarterra-bio.com

Carterra- LSA platform firmographics

Firmographics
Name
Carterra- LSA platform
Legal name
Carterra, Inc.
Website
https://carterra-bio.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Carterra- LSA platform industry classification

Industry
Product category
Biopharmaceutical Analytical Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAAAIAA
High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Surface plasmon resonance
  • Antibody screening platforms
  • Kinetics characterization
  • Epitope binning systems
  • Biopharmaceutical instrumentation

Where Carterra- LSA platform is headquartered

Location

Headquarters

HQ city
Salt Lake City
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Carterra- LSA platform business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SPR Instrumentation Sales: Sale of high-throughput SPR instruments including LSA, LSAXT, Ultra, and Carterra Vega platforms. Instruments are capital equipment requiring significant investment, sold through enterprise field sales.
  2. Sensor Chips and Consumables: Recurring revenue from proprietary sensor chips (HC, CMD, NiNTA, Streptavidin, Protein A/G series) and consumables required for SPR operations. Online store available for chip purchases.
  3. Software Licenses and Updates: Kinetics and Epitope Data Analysis Software with regular version updates. Software updates released periodically (e.g., V.2.0.0.5078 in October 2025) with new features and capabilities.
  4. Service and Support: Technical support, application training programs, and service contracts for installed customer base. Dedicated support team with phone and email contact options.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Carterra- LSA platform product offering

Product offering

Core offering

Carterra designs, manufactures, and sells high-throughput Surface Plasmon Resonance (HT-SPR) instrumentation and associated consumables and software for antibody screening, kinetic characterization, and epitope binning. The LSA, LSAXT, Ultra, and Vega instruments measure binding interactions for therapeutic discovery at biopharmaceutical companies, biotechs, and academic and government research organizations, complemented by proprietary sensor chips, Navigator control software, and Kinetics and Epitope Data Analysis Software.

Product overview

Carterra offers a portfolio of four HT-SPR (High-Throughput Surface Plasmon Resonance) platforms sharing common technology and software. The Carterra LSA serves as the core antibody characterization platform for detailed kinetics and epitope binning. The LSAXT extends capabilities with enhanced sensitivity for PROTACs, kinases, and cytokines. The Ultra platform targets small molecule and fragment screening with maximum sensitivity. The Vega represents the latest addition as a 48-channel parallel SPR platform for massively increased throughput. All instruments share common Navigator software for experiment control, Kinetics Data Analysis Software for kinetic screening, and Epitope Data Analysis Software for binning analysis. The platforms are complemented by a range of sensor chip consumables and integrated AI/ML tools for data-driven drug discovery.

Differentiator

Problem solved

Functional benefit

Brands

  • Carterra LSA: High-throughput SPR platform for detailed antibody kinetic and epitope binning characterization, supporting up to 384x384 interactions.
  • Carterra LSAXT
  • Carterra Ultra
  • Carterra Vega
  • Kinetics Data Analysis Software
  • Epitope Data Analysis Software

Products and services

  • Carterra LSA High-throughput SPR instrument for detailed antibody kinetic analysis and epitope binning, enabling screening of up to 1,152 monoclonal antibodies in a single unattended run for pharmaceutical and biotech discovery teams.
  • Carterra LSAXT Enhanced sensitivity SPR instrument for PROTAC, kinase, cytokine, DEL, and protein-protein inhibitor screening and characterization, designed for biotherapeutic discovery teams.
  • Carterra Ultra High-sensitivity HT-SPR instrument for small molecule and fragment screening with 96-channel printhead, advanced microfluidics, and capacity for up to 768 fragments or 1,152 mAbs per run.
  • Carterra Vega 48-channel parallel HT-SPR platform delivering 12x the throughput of leading 8-channel SPR systems, screening over 20,000 analytes per day for high-volume biotherapeutic and small molecule discovery programs.
  • Sensor Chips Proprietary biosensor chips including HC, CMD, NiNTA, Streptavidin, Protein A, and Protein A/G surface chemistries used as consumables for Carterra HT-SPR instruments.
  • Kinetics Data Analysis Software High-throughput kinetics analysis software for screening and ranking up to 1,152 monoclonal antibodies with rapid data fitting, visualization, quality validation, and interactive on-rate, off-rate, affinity, and iso-affinity plots.
  • Epitope Data Analysis Software Epitope binning and mapping analysis software for processing massive 384x384 HT-SPR datasets with heat maps, dendrograms, network plots, and stacked plots for visualization.
  • Navigator Software Experiment setup and run control software with assay wizards enabling complex assay setup in under 5 minutes, fully automated experiments, real-time binding data collection, and up to 7 days of unattended operation.
  • AI, ML and Synthetic Biology Tools Integrated AI/ML workflows and synthetic biology tools leveraging Carterra HT-SPR binding data to support machine learning and generative AI applications in antibody design and drug discovery.

Quantifiable outcome

  • 90 days from antibody screening initiation to human treatment (Eli Lilly COVID-19 antibody program)
  • +3 more outcomes

Companies that use Carterra- LSA platform

Customer profile

Named customers18 records

Segments5 records

Ideal customer profiles4 records

Carterra- LSA platform technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature8 records

Carterra- LSA platform partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and strategic.

  • Revvity SignalscoreTechnology or IntegrationIntegration partnership with Revvity's Signals VitroVivo (formerly Signals Screening) software v2.7+ for data management. Enables single repository for organizing HT-SPR experimental data, comparison with orthogonal methods, and integration with TIBCO Spotfire analytics. Supports AI/ML workflows with curated data.
  • Generate BiomedicinescoreTechnology or IntegrationGenerate Biomedicines uses Carterra LSA as integral part of their machine learning-driven protein design platform. Quote from Brett Blakeley, Senior Scientist: 'The Carterra LSA is the only instrument that can deliver high-resolution binding data at this level of throughput.' Demonstrates platform utility for AI/ML applications.
  • AbscicoreTechnology or IntegrationAbsci uses Carterra LSA platform for AI in medical research, leveraging HT-SPR data for machine learning applications in drug discovery.
  • Carna BiosciencesstrategicTechnology or IntegrationCollaboration with Carna Biosciences to develop kinase drug discovery solutions. Carterra uses Carna Biosciences kinases for demonstrating kinome profiling capabilities on their platforms.
  • GSKstrategicTechnology or IntegrationGSK collaboration for DNA-encoded library screening and hit validation using HT-SPR technology. Carterra presented at GSK on high-throughput SPR applications in DEL screening.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Carterra- LSA platform competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific: Thermo Fisher is a broad incumbent in life-science analytical instruments, offering a portfolio that includes biophysical characterization tools (e.g., MicroCal PEAQ-ITC, GCI systems) and adjacent label-free technologies. While not a direct SPR competitor, Thermo Fisher competes broadly for the same pharma instrument budgets.
  • Bruker: Bruker operates a broader life-science instrumentation portfolio and has participated in SPR-related technologies through acquisitions. While not a single-product SPR competitor, Bruker is a broad incumbent in life-science analytical instruments that occasionally overlaps with Carterra's customer workflows.
  • Agilent Technologies: Agilent provides a broad portfolio of analytical and life-science instruments, including biophysical characterization and screening tools that serve overlapping biopharma customers. While not a focused SPR competitor, Agilent competes at the portfolio level for instrument wallet share at major pharma accounts.

Others

  • Revvity (formerly PerkinElmer Life Sciences): Revvity provides data management and analytics software (Signals VitroVivo/Screening) that integrates with Carterra LSA instruments for pharma screening workflows. It is an enabling technology partner and adjacent ecosystem participant rather than a direct SPR competitor.

Direct peers

  • Reichert Technologies: Reichert (part of Ametek) manufactures SPR-based instruments (e.g., SR7500DC) for label-free interaction analysis in research and pharma settings. Reichert is a long-standing SPR competitor with a smaller installed base than Biacore but overlapping customer workflows in protein characterization.
  • Sartorius (Octet - BLI): Sartorius markets the Octet platform based on bio-layer interferometry (BLI), the principal orthogonal label-free binding kinetics technology competing with SPR in antibody characterization and screening workflows at biopharma customers. Octet targets many of the same use cases (kinetics, epitope binning, quantitation) as Carterra's HT-SPR.
  • Cytiva (Biacore): Cytiva (formerly GE Healthcare Life Sciences) manufactures the Biacore line of SPR instruments, the entrenched incumbent in label-free binding kinetics for biopharma R&D. Biacore is the closest direct competitor to Carterra across the same customer base, with decades of installed instruments at virtually every major pharma company.

Emerging players

  • Nicoya Lifesciences: Nicoya offers OpenSPR, a benchtop localized surface plasmon resonance (LSPR) instrument targeted at academic and smaller biotech researchers. It is an emerging player competing in entry-level SPR workflows and represents a differentiated price-point alternative to Carterra's high-throughput platforms.
  • Attana: Attana develops label-free biosensor instruments based on QCM (quartz crystal microbalance) technology for real-time interaction analysis. As a smaller, niche player in label-free kinetics, Attana competes with Carterra in select academic and biotech segments for binding characterization applications.
  • NanoTemper Technologies (Monolith): NanoTemper's Monolith platform uses microscale thermophoresis (MST) for label-free binding affinity analysis, competing with SPR and BLI in protein-small molecule and protein-protein interaction characterization. It is an emerging player in adjacent label-free biophysics serving overlapping pharma/biotech customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Carterra- LSA platform social profiles

Digital presence

Carterra- LSA platform financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Carterra- LSA platform leadership team

Management profile

Number of profiles

Carterra- LSA platform funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Carterra- LSA platform M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carterra- LSA platform

What does Carterra- LSA platform do?

Carterra designs, manufactures, and sells high-throughput Surface Plasmon Resonance (HT-SPR) instrumentation and associated consumables and software for antibody screening, kinetic characterization, and epitope binning. The LSA, LSAXT, Ultra, and Vega instruments measure binding interactions for therapeutic discovery at biopharmaceutical companies, biotechs, and academic and government research organizations, complemented by proprietary sensor chips, Navigator control software, and Kinetics and Epitope Data Analysis Software.

Is Carterra- LSA platform a public or private company?

Carterra- LSA platform is a private company. It is classified as unknown and is currently operating.

When was Carterra- LSA platform founded?

Carterra- LSA platform was founded in 2005. It employs 51 to 100 people.

Where is Carterra- LSA platform based?

Carterra- LSA platform is headquartered in Salt Lake City, United States, in the North America region.

How does Carterra- LSA platform make money?

Four revenue lines are on record. SPR Instrumentation Sales are the primary driver. The others are sensor Chips and Consumables, software Licenses and Updates and service and Support.

Who are Carterra- LSA platform's main competitors?

Broad incumbents on record are Thermo Fisher Scientific, Bruker and Agilent Technologies. Revvity (formerly PerkinElmer Life Sciences) is listed as an others. Direct peers are Reichert Technologies, Sartorius (Octet - BLI) and Cytiva (Biacore). Emerging players are Nicoya Lifesciences, Attana and NanoTemper Technologies (Monolith).

Does Carterra- LSA platform have an API?

No public API is recorded for Carterra- LSA platform.

What industry is Carterra- LSA platform in?

Carterra- LSA platform's product category is Biopharmaceutical Analytical Instruments. Its primary akta.pro industry code is HLAAAIAA, High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales